Hypothermic machine perfusion for uterus transplantation.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 10 03 2023
revised: 14 08 2023
accepted: 15 08 2023
medline: 28 11 2023
pubmed: 4 9 2023
entrez: 3 9 2023
Statut: ppublish

Résumé

To describe the feasibility of hypothermic machine perfusion (HMP) in uterus transplantation (UT) to potentially improve the preservation of the uterus and enhance graft preservation in the donation after brainstem death (DBD) context. Uterus transplantation is a new surgical approach to treating absolute uterine infertility; it can be performed after living donation or after DBD. In the DBD context, the uterus is typically the last organ removed after other vital organs, with the exception of the Baylor team, which removes the uterus first. This key aspect imposes an unavoidable mild temperature ischemia for >1 hour on the uterus during the removal of the vital abdominal and chest organs. In renal transplantation, the perfusion machine reduces the risk of delayed graft function; thus, we hypothesized that machine perfusion could result in a reduction of uterus graft dysfunction. The uterus graft dysfunction could be expressed by a low embryo implantation rate, pregnancy loss, or vascular pregnancy diseases such as preeclampsia or fetal growth restriction." To date, static cold storage of the uterus is the only standard method for preservation before transplantation. HMP is an emerging method that could potentially improve the preservation of the uterus to enhance graft preservation in the DBD context. This video article shows all the technical details of using the HMP for uterine transplantation. University. Porcine model. Porcine uterus was retrieved from a DBD domestic animal model and flushed with KPS MP (Bridge To Life Ltd in UK) at 4 °C. After vascular preparation on the back table, the uterus was perfused using KPS MP through a cannula in the aorta using the VitaSmart device (Bridge To Life Ltd in UK) for 18 hours. Then, the uterus was transplanted to the porcine recipient. The macroscopic appearance of the uterus at the end of HMP and the assessment of the uterus vascularization after transplantation in the recipient compared with the native uterus. This video shows the cannulation of the iliac vessels, cooling and removal of the uterus on a porcine model, uterus preservation using HMP during 18 hours, and then UT in a new recipient pig with the reperfusion of the transplanted uterus next to the native, intact uterus of the recipient. The macroscopic appearance of the uterus at the end of HMP appeared viable and was perfectly flushed. The assessment of the uterus vascularization after transplantation in the recipient was similar to that of the native uterus. To our knowledge, we describe here for the first time the UT procedure in DBD context on an animal model and the use of HMP for uterus preservation in UT programs; this could increase the number of uterine grafts available for a greater number of female recipients. Hypothermic machine perfusion could allow the duration of cold ischemia to be prolonged without altering the uterine graft. Nevertheless, this assertion has to be validated in a human context.

Identifiants

pubmed: 37660880
pii: S0015-0282(23)00781-1
doi: 10.1016/j.fertnstert.2023.08.020
pii:
doi:

Types de publication

Video-Audio Media Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1259-1261

Informations de copyright

Copyright © 2023 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests L.D. has received nonfinancial support (loan of infusion machine) from VitaSmart for the submitted work and funding from Biomedicine Agency call for tenders Graft. C.S. has nothing to disclose. K.B. reports nonfinancial support (loan of infusion machine) from VitaSmart for the submitted work. D.V.L. has nothing to disclose. S.J. has nothing to disclose. N.R.L. has nothing to disclose. E.F. has nothing to disclose. V.L. has nothing to disclose.

Auteurs

Ludivine Dion (L)

Department of Gynecology, Rennes University Hospital, Hôpital Sud, France; Irset - Inserm UMR_S 1085, Rennes, France. Electronic address: ludivine.dion@chu-rennes.fr.

Carla Sousa (C)

Department of Gynecology, Rennes University Hospital, Hôpital Sud, France.

Karim Boudjema (K)

Department of Hepatobiliary Surgery and Liver Transplantation, Rennes University Hospital, Pontchaillou, France.

David Val-Laillet (D)

Nutrition Metabolisms and Cancer (NuMeCan), INRAE, INSERM, Univ Rennes, St Gilles, France.

Sylvie Jaillard (S)

Irset - Inserm UMR_S 1085, Rennes, France; Department of Cytogenetics and Cell Biology, Rennes University Hospital, Pontchaillou, France.

Nathalie Rioux-Leclercq (N)

Irset - Inserm UMR_S 1085, Rennes, France; Department of Pathology, Rennes University Hospital, Pontchaillou, France.

Erwan Flecher (E)

Department of Thoracic and Cardiovascular Surgery, Rennes University Hospital, Pontchaillou, France; Signal and Image Treatment Laboratory (LTSI), Inserm U1099, Rennes, France.

Vincent Lavoue (V)

Department of Gynecology, Rennes University Hospital, Hôpital Sud, France; Irset - Inserm UMR_S 1085, Rennes, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH